Glossary
Wegovy
Updated February 28, 2026
Wegovy is a prescription medication containing semaglutide, a GLP-1 receptor agonist designed to help with weight management. It works by reducing appetite and helping you feel full longer, making it easier to maintain a calorie deficit. While this can be incredibly helpful for weight loss, the key is ensuring you still eat enough protein and maintain your strength training to preserve muscle mass as you lose weight.
Identity and positioning
Wegovy contains semaglutide, a GLP-1 receptor agonist that helps people stick to a calorie deficit by reducing appetite and slowing gastric emptying. The key physique consideration is maintaining protein intake and resistance training so that weight loss comes primarily from fat rather than muscle.
| Item | Practical description |
|---|---|
| Active ingredient | semaglutide |
| Medication family | GLP-1 receptor agonist |
| Primary planning lens | weight-management execution support |
| Physique priority | protect protein and resistance training so weight loss is more fat than lean |
Physique-first cut protocol
A successful approach with Wegovy focuses on moderate deficits that preserve training performance and lean mass retention. This means prioritizing protein intake and resistance training consistency over aggressive calorie restriction.
| Control point | Practical move | What it prevents |
|---|---|---|
| Deficit sizing | moderate deficit that preserves training output | strength loss and rebound hunger |
| Protein floor | repeatable protein anchors across the week | lean-mass loss during rapid appetite suppression |
| Training consistency | keep resistance training stable; adjust volume before frequency | "I'm losing weight but looking smaller" outcomes |
| Meal structure | templates for low-appetite days | skipped meals and micronutrient collapse |
Side-effect management that preserves adherence
Common side effects like nausea and constipation can derail progress if not managed proactively. The goal is to adjust meal timing, size, and composition to work with the medication's effects rather than fighting them.
| Friction | Why it happens | Practical fix |
|---|---|---|
| Nausea and early fullness | meal size, speed, and fat load exceed tolerance | smaller meals, slower pace, and simpler fat choices until stable |
| Constipation | low food volume plus inconsistent fluids | stabilize hydration and ramp fiber gradually |
| Food aversion | appetite reduction narrows preference | use simpler protein formats and repeatable meals |
Monitoring and adjustment
Regular monitoring helps distinguish between normal adaptation and concerning patterns that require intervention. Pay attention to both performance metrics and body composition changes, not just scale weight.
| Signal | Interpretation | Next move |
|---|---|---|
| Weight down but waist unchanged | likely water noise or low-quality deficit | hold steady, audit intake accuracy and sodium/hydration pattern |
| Strength down across multiple sessions | under-fueling or recovery failure | raise intake and stabilize training before tightening deficit |
| Plateau over 2+ weeks with good adherence | adaptation or hidden drift | follow weight loss plateau checks before changing targets |
Safety and escalation thresholds
Certain symptoms require immediate medical attention and should never be ignored or managed through dietary adjustments alone. Know when to pause your fat loss plan and seek professional guidance.
| Signal pattern | Why it matters | Next step |
|---|---|---|
| Severe abdominal pain with persistent vomiting | pancreatitis or gallbladder complication risk | urgent clinical evaluation |
| Persistent inability to hydrate or eat enough to function | under-fueling risk | pause aggressive fat loss and seek medical guidance |
| Pregnancy or trying to conceive | medication safety constraints | clinician-led plan only |
Use meal planning, protein quality, and body composition to keep Wegovy-driven appetite changes aligned with physique outcomes instead of only scale weight.